Cite

HARVARD Citation

    Tas, M. et al. (2022). Refractory Stage M Ganglioneuroblastoma With Bone Metastases and a Favorable, Chronic Course of Disease. Journal of pediatric hematology/oncology. 44 (1), p. . [Online]. 
  
Back to record